JAMA Cardiol 5:11821190 Chilton R, Tikkanen I, Cannon CP, Crowe S, Woerle HJ, Broedl UC, Johansen OE (2015) Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
1a, S91) as the main C16orf87 phosphorylation site mimicking a minimal Akt/PKB kinase consensus recognition motif (R-X-R-X-X-S/T, Fig
Potential topics include, but are not limited to: HGF/c-Met system pathways The biochemical characteristics of HGF and c-Met The interaction between HGF/c-Met axis and non-coding RNA The role of HGF/c-Met in carcinogenesis Recent advances in cancer therapies, based on interference with the HGF/c-Met axis The HGF/c-Met pathway has been associated with normal development, organ regeneration and cancer
Patients seeking reimbursement should contact their insurance provider directly to confirm coverage
Morton, D